# Kira Biotech

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/kira-biotech-pty

- Industry: Healthcare
- Headquarters: Brisbane, Australia
- Website: www.kirabiotech.com
- Total disclosed funding: $11M
- Latest round: Series A (Apr 16, 2019)
- Investors on record: 3

## About

Founded in 2019 and based in Brisbane, Australia, Kira Biotech Pty Ltd is a biotechnology company that develops immunomodulatory compounds for the treatment of immune system disorders. The company develops the product, KB312, an immune-cell depleting monoclonal antibody that targets activated immune cells and restores homeostasis through the induction of immune tolerance.

## Funding rounds

- Series A, Apr 16, 2019, $11M — Longview Innovation, OneVentures, Queensland Government

## Investors

- Longview Innovation (https://capitalatlas.ai/funds/longview-innovation) — Series A
- OneVentures (https://capitalatlas.ai/funds/oneventures) — Series A
- Queensland Government — Series A